A digital companion, purpose-built for surgical patients’ pre- and post-operative journeys, is now an imperative for providers, payers, and medtech leaders aiming to achieve competitive differentiation, clinical excellence, and sustainable business value.
We stopped squeezing every last patient slot out of our clinicians. Here’s what happened…
Telehealth provider launched new platform offering $29 insurance-free online consultations, including online prescription refill, telehealth urgent care, and prescription for acne.
Increasing patient demand, barriers to access, and elevated costs are pushing healthcare providers to reconsider traditional clinical and operational workflows to meet growing challenges and improve patient outcomes. Artificial intelligence (AI), robotics, and digital therapeutic solutions are streamlining processes and expanding the possibilities for reimagining care delivery. As these technologies converge, the shift from complex high-cost interventions toward lighter more adaptive care models creates opportunity to better meet the needs of diverse patient populations.
This silent crisis has dire consequences. Patients face delays, errors increase and the entire system suffers. This cannot continue. But in the face of such crippling challenges, how can healthcare practices look to improve the interoperability of their systems?
careviso Survey Highlights Major Communication Gaps in Healthcare, Impacting Financial Transparency and Patient Experience
Health equity can provide equal opportunity for patients to achieve the best care possible. Medtech leaders from Boston Scientific, Sequel Med Tech, and ZEISS Medical Technology share how healthcare delivery, data transparency, and industry collaboration can provide more value to patients.
AI and real-time data enhance care efficiency and access. And with healthcare workers in short supply, the rapid advancements in AI, IoMT, and related innovation offer patient access freedom, enhanced care delivery, and better outcomes.
The value-based care model, with a substantial monetary budget, necessitates on-time and correct risk stratification. As a result, new and incumbent care providers and payers are reinventing healthcare delivery, looking towards cutting-edge GenAI and machine learning technology to radically transform the healthcare delivery paradigm. This article explores how GenAI and machine learning-based risk stratification are revolutionizing a new era of personalized care, resulting in improved healthcare functions for payers and providers.
The U.S. Food and Drug Administration’s (FDA’s) Center for Devices and Radiological Health (CDRH) has developed a discussion paper, Health Equity For Medical Devices, and seeks input from the public on advancing health equity on the context of medical devices.
